| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734349 | Surgery | 2017 | 12 Pages |
Abstract
Liver transplantation may provide a survival benefit among patients with diffuse neuroendocrine tumors metastases to the liver. However, due to high recurrence rates, strict selection of patients is critical. Due to the scarcity of available grafts and the lack of level 1 evidence, the recommendations to endorse liver transplantation for extensive liver neuroendocrine tumors metastases warrants ongoing deliberations.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Dimitrios MD, MSc, PhD, MACS, Diamantis I. MD, Ioannis MD, Eliza W. MD, Evangelos MD, PhD, Spiridon MD, PhD, John J. MD, PhD, FAASLD, Timothy M. MD, MPH, PhD,